These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 10366369

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.
    Pineo GF, Hull RD.
    Baillieres Clin Haematol; 1998 Sep; 11(3):621-37. PubMed ID: 10331096
    [Abstract] [Full Text] [Related]

  • 25. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR.
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV, CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.
    N Engl J Med; 2001 Mar 01; 344(9):626-31. PubMed ID: 11228276
    [Abstract] [Full Text] [Related]

  • 28. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC, Köhrmann M, Huttner HB, Schellinger PD.
    Expert Opin Drug Saf; 2009 Sep 01; 8(5):585-97. PubMed ID: 19614560
    [Abstract] [Full Text] [Related]

  • 29. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct 01; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 30. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.
    Iorio A, Agnelli G.
    Arch Intern Med; 2003 Oct 01; 160(15):2327-32. PubMed ID: 10927730
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
    Magee KD, Sevcik W, Moher D, Rowe BH.
    Cochrane Database Syst Rev; 2003 Oct 01; (1):CD002132. PubMed ID: 12535430
    [Abstract] [Full Text] [Related]

  • 33. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism.
    Merli GJ.
    Am J Phys Med Rehabil; 2000 Oct 01; 79(5 Suppl):S9-16. PubMed ID: 10994898
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.
    Hettiarachchi RJ, Prins MH, Lensing AW, Buller HR.
    Curr Opin Pulm Med; 1998 Jul 01; 4(4):220-5. PubMed ID: 10813237
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Low-molecular-weight heparin in the treatment of venous thromboembolism.
    Hull RD, Pineo GF.
    Semin Thromb Hemost; 2000 Jul 01; 26 Suppl 1():61-7. PubMed ID: 11011809
    [Abstract] [Full Text] [Related]

  • 39. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.
    Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G.
    Arch Intern Med; 2000 Jan 24; 160(2):181-8. PubMed ID: 10647756
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.